Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:19   Issue: 1
Pp: 1-1
William Cho
DOI: 10.2174/156800961901181204125605
Published on: 13 December, 2018



Preface free to download

Volume:19   Issue: 1
Pp: 2-2
Ruiwen Zhang
DOI: 10.2174/156800961901181204125705
Published on: 13 December, 2018



Targeted Nanotechnology from Bench to Bedside promotion: free to download

Volume:19   Issue: 1
Pp: 3-4
Konstantinos Sapalidis, Christoforos Kosmidis, Stela Laskou, Athanasios Katsaounis, Stylianos Mantalobas, Ioannis Passos, Nikolaos Michalopoulos, Aikaterini Amaniti, Chrysa Sardeli and Paul Zarogoulidis*
DOI: 10.2174/156800961901181204130142
Published on: 13 December, 2018



Cutaneous Application of Celecoxib for Inflammatory and Cancer Diseases

Volume:19   Issue: 1
Pp: 5-16
Oliesia Gonzalez Quiñones and Maria Bernadete Riemma Pierre*
DOI: 10.2174/1568009618666180430125201
Published on: 13 December, 2018




Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression

Volume:19   Issue: 1
Pp: 17-25
Liwei Lang, Austin Y. Shull and Yong Teng*
DOI: 10.2174/1568009618666180319091731
Published on: 13 December, 2018




Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?

Volume:19   Issue: 1
Pp: 26-40
A.P. Alves, A.C. Mamede, M.G. Alves, P.F. Oliveira, S.M. Rocha, M.F. Botelho and C.J. Maia*
DOI: 10.2174/1568009618666180430144441
Published on: 13 December, 2018




Crizotinib Versus Chemotherapy on ALK-positive NSCLC: A Systematic Review of Efficacy and Safety

Volume:19   Issue: 1
Pp: 41-49
Mingxia Wang, Guanqi Wang, Haiyan Ma and Baoen Shan*
DOI: 10.2174/1568009617666170623115846
Published on: 13 December, 2018




The Association of Neuronal Stress with Activating Transcription Factor 3 in Dorsal Root Ganglion of in vivo and in vitro Models of Bortezomib- Induced Neuropathy

Volume:19   Issue: 1
Pp: 50-64
Yiting Yin, Xin Qi, Yuan Qiao, Huaxiang Liu, Zihan Yan, Hao Li and Zhen Liu*
DOI: 10.2174/1568009618666181003170027
Published on: 13 December, 2018




Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate

Volume:19   Issue: 1
Pp: 65-73
Marzieh Ghanemi, Aminollah Pourshohod, Mohammad Ali Ghaffari, Alireza kheirollah, Mansour Amin, Majid Zeinali* and Mostafa Jamalan*
DOI: 10.2174/1568009617666170427105417
Published on: 13 December, 2018




Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer open access plus

Volume:19   Issue: 1
Pp: 74-80
Peng Liu, Hailin Tang, Jiali Wu, Xingsheng Qiu, Yanan Kong, Lijuan Zhang, Xinhua Xie* and Xiangsheng Xiao*
DOI: 10.2174/1568009618666180709163718
Published on: 13 December, 2018